# OnCo record irae-myocarditis (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/irae-myocarditis/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "irae-myocarditis" ;
  schema:name "Immune-related myocarditis from checkpoint inhibitors"@en ;
  schema:alternateName "checkpoint inhibitor myocarditis"@en, "ICI myocarditis"@en, "immune checkpoint inhibitor-associated myocarditis"@en, "immunotherapy heart inflammation"@en, "myocarditis-myositis-myasthenia overlap"@en ;
  schema:description "Rarely, immunotherapy inflames the heart muscle. It usually starts in the first three months and can be fatal, so new chest pain, breathlessness, palpitations, fainting, or new muscle weakness, drooping eyelids or double vision need urgent assessment. It is treated in hospital with very high-dose steroids straight away."@en ;
  schema:url <https://onco.cc/protocols/irae-myocarditis/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "irae", "acute-oncology", "cardio-oncology" ;
  onco:related <https://onco.cc/protocols/irae-neurological/>, <https://onco.cc/protocols/checkpoint-inhibitor-baseline-and-monitoring/>, <https://onco.cc/protocols/irae-rheumatological/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cardiac-biomarker-monitoring/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/tremelimumab/>, <https://onco.cc/drugs/avelumab/>, <https://onco.cc/drugs/dostarlimab/>, <https://onco.cc/drugs/methylprednisolone/>, <https://onco.cc/drugs/alemtuzumab/> ;
  onco:institutions <https://onco.cc/institutions/sitc/>, <https://onco.cc/institutions/asco/>, <https://onco.cc/institutions/esmo/> ;
  onco:terms <https://onco.cc/terms/myocarditis/>, <https://onco.cc/terms/irae/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-asco-irae-guideline-jco-2021/>, <https://onco.cc/key-papers/paper-lyon-eur-heart-j/> .